Closed System– tag –
-
Miltenyi Biotec Builds Scalable Global T-Cell Manufacturing Platform Using Automated, Closed Systems
Bioprocess Online / Miltenyi Biotec Germany Overview Miltenyi Biotec is actively developing a scalable global T-cell manufacturing platform that leverages automated, closed systems. The strategy emphasizes integrating six critical produc... -
U.S. Stem Cell Manufacturing Market Forecast to Reach $4.04 Billion, Driven by Innovative Technologies and Automation from Thermo Fisher, Lonza, and Sartorius
openPR.com USA Overview This article summarizes a report on the U.S. stem cell manufacturing market, projected to reach $4.04 billion, driven by innovative technologies and strategic initiatives from key players. Thermo Fisher Scientific... -
Miltenyi Biotec’s Global T-Cell Manufacturing Platform Integrates Automated Closed Systems, Cuts Manual Labor by Over 70%, Achieves High Yields
Bioprocess Online Germany Overview Miltenyi Biotec proposes that global scaling of TCR-T cell manufacturing requires a fundamental process redesign, integrating six key production steps into a single automated, closed system. This integr... -
Cellares and Ori Biotech Lead Automated Cell Therapy Production Market with FDA Advanced Manufacturing Technology Designation
Fierce Pharma USA Overview A Tracxn report highlights Cellares and Ori Biotech as dominant leaders in automated cell therapy production, both holding FDA's Advanced Manufacturing Technology (AMT) designation. Their closed systems aim to ... -
REPROCELL Standardizes and Streamlines PBMC Processing for Multi-Site Clinical Trials with Semi-Automated, Closed Systems and Fully Automated Microfluidic Platforms
REPROCELL Japan Overview A REPROCELL article addresses challenges in Peripheral Blood Mononuclear Cell (PBMC) processing for multi-site clinical trials by introducing innovative solutions to enhance efficiency and standardization. Improv...
12